Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Hum Mol Genet. 2012 Feb 1;21(3):635-46. doi: 10.1093/hmg/ddr497. Epub 2011 Nov 1.
Gain-of-toxic mutations in the N-glycosylation motif of the seipin/BSCL2 gene (namely, the N88S and S90L mutations) cause autosomal dominant motor neuron diseases, termed 'seipinopathy'. Expressed mutant seipin is improperly folded and accumulates in the endoplasmic reticulum (ER), leading to an unfolded protein response (UPR). Furthermore, cells expressing mutant seipin contain unique cytoplasmic inclusion bodies (IB) that form via a different mechanism from that of ubiquitinated inclusions, or aggresomes. Whether the formation of these IB is pathogenic or protective in neurodegenerative diseases remains unclear. Here, we determined that mutant seipin IB are negative for two well-established ER markers, immunoglobulin-heavy-chain-binding protein and calnexin, indicating a distinct compartmentalization from the main ER, and that mutant seipin IB are formed via a mechanism that is independent of major UPR transducers and ER chaperons. Electron microscopy and coexpression study with variant α1-antitrypsin cDNA showed that seipin IB are compatible with unique cytoplasmic vesicles known as ER-derived protective organelles (ERPO). We also obtained evidence that seipin IB exhibit a cytoprotective property via the attenuation of ER stress. These findings suggest that ERPO, such as seipin IB, are a novel adaptation machinery against the accumulation of unfolded proteins in the ER.
在 seipin/BSCL2 基因的 N-糖基化模体中获得毒性突变(即 N88S 和 S90L 突变)会导致常染色体显性运动神经元疾病,称为“seipinopathy”。表达的突变 seipin 折叠不正确,并在内质网(ER)中积累,导致未折叠蛋白反应(UPR)。此外,表达突变 seipin 的细胞含有独特的细胞质包涵体(IB),其形成的机制与泛素化包涵体或聚集体不同。这些 IB 的形成在神经退行性疾病中是致病的还是保护的仍然不清楚。在这里,我们确定突变 seipin IB 对两种成熟的 ER 标志物,免疫球蛋白重链结合蛋白和钙网蛋白呈阴性,表明与主要 ER 有明显的区室化,并且突变 seipin IB 的形成机制独立于主要 UPR 转导器和 ER 伴侣。电子显微镜和与变体α1-抗胰蛋白酶 cDNA 的共表达研究表明,seipin IB 与称为 ER 衍生保护细胞器(ERPO)的独特细胞质小泡相容。我们还获得了 seipin IB 通过减轻 ER 应激表现出细胞保护特性的证据。这些发现表明,ERPO,如 seipin IB,是一种针对 ER 中未折叠蛋白积累的新型适应机制。